This PDF is the current document as it appeared on Public Inspection on 08/09/2016 at 08:45 am.
Notice of registration.
Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances.End Preamble Start Supplemental Information
The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices.Start Printed Page 52909
|Noramco, Inc.||81 FR 7587||February 12, 2016.|
|Cayman Chemical Company||81 FR 9217||February 24, 2016.|
|Janssen Pharmaceutical, Inc.||81 FR 9219||February 24, 2016.|
|Insys Therapeutics, Inc.||81 FR 9220||February 24, 2016.|
|Siemens Healthcare Diagnostics, Inc.||81 FR 15565||March 23, 2016.|
|Siegfried USA, LLC||81 FR 15567||March 23, 2016.|
|Patheon Pharmaceuticals, Inc.||81 FR 15571||March 23, 2016.|
|Navinta, LLC||81 FR 20418||April 7, 2016.|
|Patheon API Manufacturing, Inc.||81 FR 22122||April 14, 2016.|
The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.Start Signature
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18921 Filed 8-9-16; 8:45 am]
BILLING CODE 4410-09-P